Key facts
- Thomas A. Satterfield Jr. filed SCHEDULE 13G for CytoSorbents Corporation Common Stock, par value $0.001 per share (CTSO).
- Disclosed ownership: 6.6%.
- Date of event: 13 Jan 2025.
Thomas A. Satterfield Jr. - 13 Jan 2025 SCHEDULE 13G Report for CytoSorbents Corporation Common Stock, par value $0.001 per share (CTSO)
- Filing Manager
- Thomas A. Satterfield Jr.
- Reporting Manager
- Thomas A. Satterfield, Jr.
- Symbol
- CTSO
- Shares outstanding
- 60,958,338 shares
- Disclosed Ownership
- 3,998,867 shares
- Ownership
- 6.6%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Jan 2025, 16:05:30 UTC
- Date of event
- 13 Jan 2025
- SEC
- View on sec.gov
Key filing fact
Thomas A. Satterfield Jr. disclosed 6.6% ownership in CytoSorbents Corporation Common Stock, par value $0.001 per share (CTSO) on 13 Jan 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Jan 2025, 16:05.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 6.6% | 3,998,867 | 550,310 | 3,448,557 | /s/ Thomas A. Satterfield, Jr. | Thomas A. Satterfield, Jr. |
CIK / CUSIP context first